Malignant Eye Neoplasm — Trials

Malignant Eye Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

446 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 83
Recruiting: 44
Ph III recruiting: 10
Growth YoY: —
Industry share: 30%
Top sponsor: IDEAYA Biosciences
Termination share: 33.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (67)

clinicaltrialsPublishedShowing 1–17 of 17 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00110110	Combination Chemotherapy and Cyclosporine Followed by Focal Therapy for Bilateral Retinoblastoma	unknown	Phase 2	71	The Hospital for Sick ChildrenOTHER	4	Apr 17, 2024	clinicaltrials
NCT03528408	Study of Adjuvant Ipilimumab and Nivolumab in Subjects With High-risk Ocular Melanoma	unknown	Phase 2	52	Suthee RapisuwonOTHER	1	Apr 11, 2023	clinicaltrials